Healthcare and Life Sciences

The water.org founders argue that the way to bring clean water and sanitation to the poor of the world at scale isn’t by drilling wells or installing toilets. Nor is it through charity alone. The solution, they say, is market-based financing.

Two Stanford Medicine leaders on AI’s potential, and what realizing it will require. By Courtney Chiang Dorman and Kate Larsen.

Will AI drive a revolution in drug discovery? Ben Hirschler examines how it is being used to sift through a mountain of health-related data—including his own biomedical records.

As we enter this new biotechnology revolution, Europe eyes competition with US dominance. By Brunswick’s Francesca Scassellati Sforzolini and Kelan Murphy.

After decades of neglect, it’s time to recognize that investing in women’s health is the right and smart thing to do. Ben Hirschler and Charis Gresser report.

As a practical matter, long-term success demands ESG discipline, says Dr. Jeane Tsutsui, CEO of Brazilian medical diagnostics company Grupo Fleury. She speaks with Brunswick’s Roberta Lippi and Daniel Wiedemann about her journey.

From “green” chemicals to carbon-neutral cement, the power of microbes to make industrial materials could play a key role in the transition away from fossil fuels. Brunswick’s Ben Hirschler reports.

A new hospital brings to the UK both state-of-the-art technology and a distinctive approach to care. Brunswick’s Aideen Lee and Kathleen Lang report.

Yes—but maybe not. It’s complicated. Scott Foster reports.

How the EU regulates AI in healthcare could have implications far beyond the continent. Brunswick’s Francesca Scassellati Sforzolini reports.

As the climate crisis deepens, Stanford Medicine is leveraging science and smart working practices to counter the threat to health. By Ben Hirschler and Jennifer Sukawaty.

Dr. Andrea Maier chooses Singapore as a base of operation for groundbreaking work in healthy longevity research and clinical practice. By Brunswick’s Sunitha Chalam.

A talk with Mike Buckley, CEO of an app for blind and low-vision people. By his friend and former colleague, Mark Palmer.

At the intersection of technology, research and clinical care stands Verily’s Amy Abernethy. By Tanisha Carino and Jennifer Sukawaty.

Not waiting for nature-positive standards, UK multinational GSK is taking action and a leadership role in the pharma and biotech sector. By Alastair Morton and Ellie Fallon.

Following his history-making turn as COVID vaccine development lead for Operation Warp Speed, Matthew Hepburn oversees pandemic preparedness at The White House Office of Science and Technology Policy.

As the European Commission gets set to review the EU’s pharmaceutical legislation, two issues demand particular attention: ensuring supplies of key medicines, especially antibiotics—and encouraging the innovation needed to maintain the therapeutic options available, which come from having new and different antibiotics. Francesca Scassellati Sforzolini, Healthcare & Life Sciences Lead, Europe, reports.

Anti-aging research is accelerating, with profound implications for society. By Ben Hirschler.

Venture philanthropy expert and public health advocate Olga Rudneva talks to us about helping Ukraine’s wounded become living symbols of a new country. By Maria Figueroa Küpçü and Carlton Wilkinson.

Brunswick’s Ben Hirschler describes taking part in a COVID-19 vaccine trial as part of the historic global effort to halt the disease.

She entered the water hoping to regain her mobility. She became a record-breaking aquatic marathoner. By Craig Mullaney.

Adrian Gore, founder and CEO of Discovery Group, talks to Brunswick’s Marina Bidoli and Georgie Armstrong about working for the greater good and the power of positivity.

One state’s readiness could serve as a model for the nation and the world. “Coronavirus Slayer” K.K. Shailaja, Kerala’s Health Minister, talks to Brunswick’s Khozem Merchant.

Former FDA Commissioner Dr. Scott Gottlieb talks to Brunswick’s Raul Damas about the evolution of medicine in the US.

As a child in Gloucestershire, England in the 1760s, Edward Jenner, creator of the first widely used vaccine, overheard a dairy maid say, “I shall never have smallpox because I have had cowpox. I shall never have an ugly pockmarked face.”

From handling mental illness, the business focus has switched to creating mental health. Poppy Jaman OBE, CEO of the City Mental Health Alliance, speaks to Brunswick’s Ann-Kathrin Richter about her life’s work.

Former US Surgeon General Dr. Jerome Adams talks with Brunswick’s Ninio Fetalvo.

Founded by England’s former Chief Medical Officer, The Trinity Challenge is engineering a collaboration between health, technology and data, for the benefit of mankind.

The Executive Director of Vaccines Europe sees cause for celebration—and concern.

Clinical trial diversity must improve to ensure drugs work for all. By Ben Hirschler.

The pharmaceutical industry is seizing the moment to both help lift society out of the pandemic and rebuild its own reputation. The clock is ticking. By Brunswick’s Ben Hirschler and Jeremy Ruch.